Table 3.
Explained variation in therapeutic warfarin dose pooled models
| Predictor/predictor group | Adjusted R2 |
|---|---|
| Clinical only | 0.17 |
| Clinical plus CYP2C9 and VKORC1 | 0.54 |
| Clinical plus CYP2C9 and VKORC1 and CYP4F2 | 0.56 |
Clinical variables were sex, age, body surface area, and target international normalized ratio.